TrialInvestigational new drugs2014

Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma.

Ajjai Alva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.